“Sensory Neuroimmune Signaling Opens a New Precision Medicine Window for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis”. Novera, vol. 1, no. 1, Apr. 2026, https://submit.noverapress.com/index.php/Novera/article/view/10.